How much does Pfizer's Lorlatinib cost?

The original drug Lorlatinib (Lorlatinib) has been launched in China and has entered the scope of Class B medical insurance. The trade name is Borrena/LORBRENA. It is developed, produced and marketed by Pfizer. The price of each box of 25mg*90 tablets may be 10,000 to 20,000. RMB, the original research version of lorlatinib currently sold in Hong Kong may cost around RMB 50,000 per box of 100 mg*30 tablets (the price may fluctuate due to the exchange rate), while the original research version of lorlatinib in Turkey may cost more than RMB 10,000 per box of 100 mg*30 tablets (the price may fluctuate due to the exchange rate).